{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:49:08Z","timestamp":1793332148091,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jfo.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T21:04:08Z","timestamp":1667077448000},"page":"1150-1159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Paediatric ocular rosacea: diagnosis and management with an eyelid-warming device and topical azithromycin 1.5%"],"prefix":"10.1016","volume":"45","author":[{"given":"D.","family":"Br\u00e9mond-Gignac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Navel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Chiambaretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2022.01.003_bib0210","first-page":"113","article-title":"Ocular Rosacea\u2013a Review","volume":"10","author":"Dhingra","year":"2017","journal-title":"US Ophthalmic Review"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5314\/wjd.v5.i2.109","article-title":"Pediatric ocular rosacea, a misdiagnosed disease with high morbidity: Proposed diagnostic criteria","volume":"5","author":"Arriaga","year":"2016","journal-title":"WJD"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1542-0124(12)70121-0","article-title":"Ocular rosacea","volume":"3","author":"Alvarenga","year":"2005","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0225","first-page":"P56","article-title":"Blepharitis Preferred Practice Pattern\u00ae","volume":"126","author":"Amescua","year":"2021","journal-title":"Ophthalmology 2019"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archdermatol.2007.50","article-title":"Cutaneous and ocular signs of childhood rosacea","volume":"144","author":"Chamaillard","year":"2008","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jfo.2022.01.003_bib0235","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2007.01.021","article-title":"Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis","volume":"114","author":"Jones","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jfo.2022.01.003_bib0240","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ICU.0000000000000399","article-title":"Pediatric blepharokeratoconjunctivitis: is there a right treatment?","volume":"28","author":"Rousta","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfo.2022.01.003_bib0245","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/ICU.0000000000000167","article-title":"Blepharokeratoconjunctivitis in children","volume":"26","author":"Hammersmith","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2022.01.003_bib0250","article-title":"An eye for azithromycin: review of the literature","volume":"10","author":"Kagkelaris","year":"2018","journal-title":"Ther Adv Ophthalmol"},{"issue":"3","key":"10.1016\/j.jfo.2022.01.003_bib0255","first-page":"544","article-title":"Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline","volume":"8","author":"Arman","year":"2015","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0260","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cxo.12557","article-title":"Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction","volume":"101","author":"Balci","year":"2018","journal-title":"Clin Exp Optom"},{"issue":"3","key":"10.1016\/j.jfo.2022.01.003_bib0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICO.0000000000002233","article-title":"The Role of Topical Azithromycin in the Treatment of Meibomian Gland Dysfunction","volume":"39","author":"Ciloglu","year":"2020","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jfo.2022.01.003_bib0270","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/ICO.0b013e3181ca38a0","article-title":"Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis","volume":"29","author":"Haque","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2022.01.003_bib0275","first-page":"2014","article-title":"Ocular rosacea: an underdiagnosed cause of relapsing conjunctivitis-blepharitis in the elderly","author":"Marchi","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jtos.2017.01.006","article-title":"Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting","volume":"15","author":"Geerling","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1475-1313.1990.tb00968.x","article-title":"Meibomian gland dysfunction: some clinical, biochemical and physical observations","volume":"10","author":"Ong","year":"1990","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"10.1016\/j.jfo.2022.01.003_bib0290","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.01.003_bib0295","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2147\/OPTH.S33133","article-title":"How to promote and preserve eyelid health","volume":"6","author":"Benitez-Del-Castillo","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0300","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.ICL.0000060998.20142.8D","article-title":"Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction","volume":"29","author":"Olson","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"7","key":"10.1016\/j.jfo.2022.01.003_bib0305","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1097\/OPX.0b013e31825c3479","article-title":"A comparison of an eyelid-warming device to traditional compress therapy","volume":"89","author":"Pult","year":"2012","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.jfo.2022.01.003_bib0310","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.clae.2013.02.009","article-title":"Evaluation of the ocular tolerance of a novel eyelid-warming device used for meibomian gland dysfunction","volume":"36","author":"Purslow","year":"2013","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.jfo.2022.01.003_bib0315","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10792-014-9947-3","article-title":"Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study","volume":"35","author":"Villani","year":"2015","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2022.01.003_bib0320","first-page":"2019","article-title":"Evaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunction","volume":"8","author":"Benitez Del Castillo","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clae.2019.09.004","article-title":"Therapeutic profile of a latent heat eyelid warming device with temperature setting variation","volume":"43","author":"Wang","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"issue":"10","key":"10.1016\/j.jfo.2022.01.003_bib0330","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jfo.2014.06.004","article-title":"Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study","volume":"37","author":"Doan","year":"2014","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0335","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1869-5760-3-38","article-title":"Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis","volume":"3","author":"Doan","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"10.1016\/j.jfo.2022.01.003_bib0340","doi-asserted-by":"crossref","first-page":"664","DOI":"10.5301\/ejo.5000103","article-title":"Pediatric ocular rosacea: 2 cases","volume":"22","author":"Miguel","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0345","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(03)00890-0","article-title":"Ocular rosacea in childhood","volume":"137","author":"Nazir","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jfo.2022.01.003_bib0350","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/eye.2015.249","article-title":"Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome","volume":"30","author":"Rodr\u00edguez-Garc\u00eda","year":"2016","journal-title":"Eye (Lond)"},{"issue":"1\u20132","key":"10.1016\/j.jfo.2022.01.003_bib0355","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40123-014-0025-8","article-title":"A Randomized, controlled treatment trial of eyelid-warming therapies in Meibomian gland dysfunction","volume":"3","author":"Sim","year":"2014","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jfo.2022.01.003_bib0360","first-page":"1797","article-title":"Emerging treatment options for meibomian gland dysfunction","volume":"7","author":"Qiao","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000455087","article-title":"The Limitation of Applying Heat to the External Lid Surface: A Case of Recalcitrant Meibomian Gland Dysfunction","volume":"8","author":"Kenrick","year":"2017","journal-title":"Case Rep Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12886-018-0700-y","article-title":"Short-term effect of a developed warming moist chamber goggle for video display terminal-associated dry eye","volume":"18","author":"Ren","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jfo.2022.01.003_bib0375","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/OPTH.S160403","article-title":"A novel system, TearCare(\u00ae), for the treatment of the signs and symptoms of dry eye disease","volume":"12","author":"Badawi","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfo.2022.01.003_bib0380","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1167\/iovs.16-19088","article-title":"Longitudinal Changes in Tear Evaporation Rates After Eyelid Warming Therapies in Meibomian Gland Dysfunction","volume":"57","author":"Yeo","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jfo.2022.01.003_bib0385","doi-asserted-by":"crossref","first-page":"169","DOI":"10.12816\/0047635","article-title":"Recurrent Chalazia Revealing an Ocular Rosacea in a Child","volume":"39","author":"Wagih","year":"2017","journal-title":"BMB"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0390","article-title":"Topical treatments for blepharokeratoconjunctivitis in children","volume":"2","author":"O Gallagher","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jfo.2022.01.003_bib0395","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/S0004-27492012000300006","article-title":"Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis","volume":"75","author":"Fadlallah","year":"2012","journal-title":"Arq Bras Oftalmol"},{"issue":"92","key":"10.1016\/j.jfo.2022.01.003_bib0400","article-title":"Role of Azithromycin in the treatment of children meibomian gland disease","volume":"92","author":"Lazreg","year":"2014","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"10.1016\/j.jfo.2022.01.003_bib0405","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2005.08.035","article-title":"Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis","volume":"141","author":"Doan","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jfo.2022.01.003_bib0410","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1111\/aos.13137","article-title":"Topical cyclosporin A as a steroid-sparing agent for ocular rosacea","volume":"95","author":"Ong","year":"2017","journal-title":"Acta Ophthalmologica"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551222001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551222001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:18:40Z","timestamp":1759259920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551222001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0181551222001310"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2022.01.003","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric ocular rosacea: diagnosis and management with an eyelid-warming device and topical azithromycin 1.5%","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}